Oppenheimer analyst Jay Olson maintained a Buy rating on Sierra Oncology (SRRA) yesterday and set a price target of $29.00.
The post Oppenheimer Reaffirms Their Buy Rating on Sierra Oncology (SRRA) appeared first on Smarter Analyst.
Oppenheimer analyst Jay Olson maintained a Buy rating on Sierra ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-reaffirms-their-buy-rating-on-sierra-oncology-srra/

#SmarterAnalyst